Timothy’s longstanding contributions to SCN, alongside his leadership in ELSI research and extensive science communication efforts, including co-founding ScienceUpFirst, have played a critical role in combating misinformation and strengthening public trust in science, with lasting impact on the regenerative medicine landscape.

Maria’s leadership in advancing interdisciplinary collaboration through initiatives such as the Virtual Human Development Consortium, and her innovative science communication through visual summaries and training, have strengthened engagement across the regenerative medicine community while enhancing accessibility and impact.

Jessica’s work advancing research on hereditary heart disease in Newfoundland and Labrador, alongside her leadership in launching the first StemCellTalks program in the province, exemplifies a deep commitment to connecting science with the communities it serves.

Marissa’s sustained contributions to SCN, including her leadership with StemCellTalks Ottawa and the National Advisory Committee, her work advancing trainee engagement through workshops and ELSI discussions, and her creative science communication through Science, Stand-Up, & Song, have engaged diverse audiences and strengthened connections between science and society.

Over the past decade, Danielle has progressed from SCN trainee to industry scientist, demonstrating strong leadership and community engagement. She currently serves as co-chair on the Global Workforce Development in Stem Cell Research and Regenerative Medicine Working Group. Through her @sciencewithspice platform, Danielle has played a key role in making  complex regenerative medicine concepts more accessible to diverse audiences.

Emilio’s outstanding mentorship and leadership of national training initiatives, including INTBIOTECH CREATE, reflect a deep commitment to supporting emerging scientists. Emilio’s dedication to fostering inclusive, accessible training environments and creating innovative learning opportunities has enabled trainees to thrive and succeed across academia and industry.

Over decades, Andras has mentored a remarkable cohort of scientists who now lead research programs, biotechnology companies, and major initiatives in Canada and internationally. Grounded in field-defining contributions to stem cell biology, Andras’s mentorship equips trainees with the expertise and independence to become leaders, helping to strengthen Canada’s regenerative medicine workforce and ecosystem.

Milica’s leadership in creating and directing innovative training initiatives, including a national NSERC CREATE program in Organ-on-a-Chip Engineering and Entrepreneurship, has established a highly interdisciplinary environment that prepares trainees for diverse career pathways. Through mentorship, translational leadership, and efforts bridging academia and commercialization, Milica has created meaningful opportunities for trainees to develop skills and contribute to real-world applications of regenerative medicine.

Bruce’s leadership in advancing stem cell-based therapies for type 1 diabetes, alongside sustained commitment to mentorship through national training initiatives such as the SCN–Breakthrough T1D Andrew McKee Fellowship Program, has provided trainees with meaningful experience across the translational pipeline. Bruce’s dedication to inclusive training and engagement, including collaborations that promote equitable and culturally informed research practices, reflects a strong commitment to preparing the next generation of researchers to deliver impactful and accessible therapies.

Peter’s longstanding commitment to mentorship and trainee development, including leadership of large-scale training initiatives such as NSERC CREATE, has had a profound and lasting impact on the field. Through dedication to fostering inclusive training environments and supporting diverse career pathways, Peter’s trainees have gone on to leadership roles across academia, industry, and beyond.

Since launching the Flamier Lab, Anthony has built an innovative research program advancing stem cell biology and regenerative medicine, leveraging human pluripotent stem cells, genome editing, and disease modeling. Anthony’s work demonstrates strong scientific rigor and translational potential, while his leadership within SCN and contributions to mentorship and innovation mark him as a rising leader in the field.

Matthew’s work strengthening the clinical translation of regenerative medicine and cell therapies, along with leadership in SCN training initiatives such as co-organizing the 2023 Preclinical Experimental Design and Reporting Workshop, highlights commitment to advancing rigorous and impactful research.

Holly’s leadership in the SCN trainee community, including roles as Vice-Chair and Chair of the Trainee Communications Committee, has had a central role in shaping impactful programming at the Till & McCulloch Meetings, developing innovative sessions that support professional growth, communication, and leadership for the next generation of scientists.

Nika’s work creating synthetic genetic circuits that help control how stem cells grow and thrive represents a novel and promising approach to improving cell therapies. Alongside her research, she is committed to supporting the next generation of scientists through mentorship and by founding Advice to a Scientist.

Tyler is an exceptional early career researcher advancing microglial therapies and precision medicine for brain disorders. Their high-impact scholarly work and two patents demonstrate strong translational promise. Tyler also leads Saskatoon’s first StemCellTalks and Indigenous-driven collaborations that support culturally informed stem cell knowledge and community engagement.

As Founder and President and CEO of STEMCELL Technologies, Allen has built a globally leading biotechnology company that has advanced research and commercialization across regenerative medicine and related fields. Allen’s leadership in establishing early bone marrow transplant programs and fostering a science-driven bioeconomy has had a profound and lasting impact in Canada and beyond.

Lucie and Véronique’s leadership in advancing tissue engineering through pan-Canadian clinical trials, including the development of bilamellar skin substitutes (SASS) and reconstructed corneal epithelium (CECA), has expanded access to innovative therapies for patients. Their efforts in strengthening clinical translation infrastructure and national collaborations have helped establish a robust ecosystem, enabling safe, reproducible, and accessible regenerative medicine solutions across Canada.

Lucie and Véronique’s leadership in advancing tissue engineering through pan-Canadian clinical trials, including the development of bilamellar skin substitutes (SASS) and reconstructed corneal epithelium (CECA), has expanded access to innovative therapies for patients. Their efforts in strengthening clinical translation infrastructure and national collaborations have helped establish a robust ecosystem, enabling safe, reproducible, and accessible regenerative medicine solutions across Canada.

As a founding member of SCN and a global leader in the ethical, legal, and social implications of biomedical research, Bartha’s work has been instrumental in shaping the frameworks that enable responsible innovation in regenerative medicine and genomics. Through leadership in developing international standards for data sharing, consent, and governance, Bartha has strengthened public trust and facilitated global collaboration while safeguarding patient rights.

As a founding member of SCN and a pioneering leader in developmental and stem cell biology, Janet’s foundational discoveries have transformed our understanding of mammalian development and laid critical groundwork for regenerative medicine. Janet’s leadership in shaping national stem cell research guidelines and strengthening Canada’s global position, alongside her longstanding commitment to mentorship and community building, has had a profound and lasting impact on the field.

Guy’s pioneering work in hematopoietic stem cells, including the co-discovery of UM171, has enabled transformative advances in stem cell transplantation and addressed critical barriers in treating blood cancers. Guy’s leadership in translating this breakthrough into clinical and commercial impact, including co-founding ExCellThera, has helped position Canada at the forefront of global cell therapy innovation.

Patrick’s longstanding contributions to SCN programming, including leadership in regulatory training, participation in webinars, and ongoing guidance on regulatory and ecosystem issues, have played an important role in strengthening the Network’s capacity and impact.

Fabio’s pioneering scientific contributions, including foundational discoveries in microglia self-renewal and muscle stem cell biology, alongside leadership in building collaborative regenerative medicine networks, have had a lasting impact on the field. Through roles in national and regional initiatives, as well as contributions to SCN governance and translational innovation, Fabio has helped strengthen Canada’s regenerative medicine ecosystem.

Breakthrough T1D’s longstanding partnership with SCN, including co-funding national research initiatives and supporting training through programs such as the J. Andrew McKee Fellowship, has played a critical role in advancing regenerative medicine research and capacity in Canada. Leadership in convening cross-sector collaborations and addressing key challenges in the development of cell therapies has further strengthened the impact of this work.

Ottawa Method Centre’s contributions to advancing rigorous translational research practices, including guidance through Blueprint Translational Research Group policy briefs and education on clinical trial design and reporting, have been invaluable to the SCN community. Leadership in promoting best practices in patient engagement and clinical research has strengthened the quality and impact of regenerative medicine research across Canada.

STEMCELL Technologies’ longstanding partnership with SCN, including financial and in-kind support for research initiatives and active leadership in governance and strategic direction, has played a critical role in advancing regenerative medicine across Canada. Contributions to training, standards development, and national knowledge exchange have further strengthened research quality and community impact.